A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...

A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including Sanofi's $1.6B acquisition ...

A major scientific breakthrough has identified the Epstein-Barr virus (EBV) as the leading cause of multiple sclerosis (MS), a chronic inflammatory disease that affects nearly 3 million people ...

Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...

Sanofi's wide lineup of branded drugs and vaccines and robust pipeline create strong cash flows and a narrow economic moat. Growth of existing products and new product launches should help offset ...

Novavax reports strong immune responses from H5N1 avian flu vaccine candidate, showing promise in single and two-dose ...

The United States will stop distributing all influenza vaccines that contain mercury-based preservative thimerosal, marking ...

The mercury-based preservative thimerosal will be removed from all flu shots distributed in United States, Health and Human ...

The action will remove from use the very few flu shots that contain the contested preservative, elevating unproven fears it ...

Secretary Robert F. Kennedy Jr. | HHS Secretary Robert F. Kennedy Jr. has signed off on a recommendation from an advisory ...